MGMT and neoplasm: We have therefore devised a new treatment strategy involving the use of a multidrug combination, including IFN-β in the initial induction therapy administered with RT, followed by maintenance therapy with TMZ and IFN-β administered for as long as possible, aimed at depleting tumor MGMT.